Akili News

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)

TipRanksNov 14, 2023 16:10 ET

TD Cowen Sticks to Its Buy Rating for Akili (AKLI)

TipRanksNov 13, 2023 10:16 ET

LifeSci Capital Reaffirms Their Buy Rating on Akili (AKLI)

TipRanksAug 15, 2023 09:15 ET

Credit Suisse Reiterates Outperform on Akili, Maintains $4 Price Target

BenzingaAug 11, 2023 09:07 ET

Akili Analyst Ratings

BenzingaAug 11, 2023 09:06 ET

Akili (AKLI) Receives a Buy From LifeSci Capital

TipRanksJun 10, 2023 12:55 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch Health Companies (BHC), PTC Therapeutics (PTCT) and Akili (AKLI)

TipRanksMay 18, 2023 05:31 ET

LifeSci Capital Reaffirms Their Buy Rating on Akili (AKLI)

TipRanksMay 15, 2023 17:35 ET

Akili (AKLI) Gets a Buy From LifeSci Capital

TipRanksMay 3, 2023 19:05 ET

LifeSci Capital Reaffirms Their Buy Rating on Akili (AKLI)

TipRanksMar 11, 2023 16:51 ET

Morgan Stanley Sticks to Its Hold Rating for Akili (AKLI)

TipRanksJan 25, 2023 11:31 ET

Morgan Stanley Adjusts Price Target on Akili to $3 From $2, Maintains Equal-Weight Rating

MT NewswiresJan 25, 2023 10:28 ET

Akili Analyst Ratings

Benzinga Analyst RatingsJan 25, 2023 08:03 ET

Morgan Stanley Maintains Equal-Weight on Akili, Raises Price Target to $3

Benzinga Real-time NewsJan 25, 2023 08:02 ET

LifeSci Capital Reaffirms Their Buy Rating on Akili (AKLI)

TipRanksJan 13, 2023 19:00 ET

Update: Morgan Stanley Initiates Akili at Equalweight, $2 Price Target, Cites Uncertainties Regarding EndeavorRx's Launch

MT NewswiresDec 28, 2022 09:20 ET

Akili Analyst Ratings

Benzinga Analyst RatingsDec 28, 2022 06:28 ET

Morgan Stanley Initiates Coverage On Akili With Equal-Weight Rating, Announces Price Target of $2

Benzinga Real-time NewsDec 28, 2022 06:28 ET

Akili Analyst Ratings

Benzinga Analyst RatingsNov 18, 2022 07:43 ET

B of A Securities Initiates Coverage On Akili With Neutral Rating, Announces Price Target of $2

Benzinga Real-time NewsNov 18, 2022 07:42 ET